Skip to main content

Table 4 The NRI and IDI of the nomogram in overall survival prediction for squamous cell uterine cervical carcinoma patients received definitive radiotherapy compared with FIGO2018 stage system in validation set

From: A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy

Index

Estimate

95% CI

P value

NRI (vs. FIGO2018 stage)

 For 3-year OS

0.21

0.07–0.36

 < 0.01

 For 5-year OS

0.38

0.23–0.53

 < 0.001

 For 7-year OS

0.38

0.20–0.56

 < 0.001

 IDI (vs. FIGO2018 stage)

 For 3-year OS

0.08

0.03–0.13

 < 0.01

 For 5-year OS

0.14

0.08–0.19

 < 0.001

 For 7-year OS

0.10

0.005–0.15

 < 0.001

  1. FIGO International Federation of Gynecology and Obstetrics, NRI Net reclassification improvement, IDI Integrated discrimination improvement, OS Overall survival
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us